Football Players Health Study In Person Assessments Study

CompletedOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Cardiac DysfunctionNeurocognitive DiseaseChronic PainSleep Apnea
Interventions
DIAGNOSTIC_TEST

Echocardiography

Cardiac ultrasound to measure left ventricular systolic function.

DIAGNOSTIC_TEST

Neuropsychological Testing

Standard clinical testing designed to establish or exclude the presence of cognitive dysfunction.

DIAGNOSTIC_TEST

Quantitative Sensory Testing

Clinically accepted quantitative assessment of chronic pain burden.

DIAGNOSTIC_TEST

Nocturnal Polysomnography

Routine overnight sleep study to measure apnea-hypopnea index.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Harvard Medical School (HMS and HSDM)

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Martinos Center for Biomedical Imaging

OTHER

collaborator

Brigham and Women's Hospital

OTHER

lead

Massachusetts General Hospital

OTHER

NCT03866564 - Football Players Health Study In Person Assessments Study | Biotech Hunter | Biotech Hunter